Login
Toggle navigation
Videos
Categories
Trending
Flash is missing. Download it from
Adobe
.
Green Finance: Investing in a Sustainable Future
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Green Finance: Investing in a Sustainable Future
Recent Videos
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences
Suggestions
00:10:00
Andreas Thorsheim, CEO of Otovo, engages in a discussion with Nordnet's analyst Roger Berntsen, covering various aspects of the company's operations.
00:10:00
Octava Minerals: Advancing Lithium, Gold, and Nickel Projects in Western Australia
00:10:00
Building Blue Owl and Innovating in Private Capital Markets | Doug Ostrover, CEO , Blue Owl Capital .
00:10:00
The Power of Proper Planning: Making Retirement Dreams a Reality
00:10:00
US-China Business Council Chairman Predicts Trade Agreement Likely, Emphasizes Mutual Interests|Evan G. Greenberg, Chairman and Chief Executive Officer, Chubb
00:10:00
Revolutionizing the Boating Industry: An Interview with Bodum CEO Joseph Johnson
00:10:00
Too Early for AI Regulation|Michael Dempsey,Managing Partner,Compound
00:10:00
The Evolution of the CLO Market: Insights from Oaktree Capital Experts Megan Messina, Ronnie Kaplan, and Brendan Beer
00:10:00
Unity and Collaboration: A Holistic Approach to Healthcare |Ahmed Banderker, CEO, Afrocentric Investment Corporation.
00:10:00
David Herro, Harris Associates portfolio manager, joins 'Squawk on the Street' to discuss the potential actions of central banks globally.
00:10:00
Unveiling the Model H: Tesla's Hydrogen-Powered Revolution|Elon Musk,CEO,Tesla
00:10:00
Accelerating Energy Transition: Javier Div's Commitment to Collaboration and Sustainability | Javier Dib , CEO, AES Andes SA.